Mometasone Furoate Alissa Healthcare Research (Mometasone Furoate Monohydrate)

Mometasone furoate, the active ingredient in Mometasone Furoate Alissa Healthcare Research, is a glucocorticoid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children.

GNH USA supplies Mometasone Furoate Alissa Healthcare Research as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a topical nasal corticosteroid that reduces inflammation in the upper airway. It is indicated for the following conditions: - Allergic rhinitis: relief of nasal congestion, itching, and sneezing caused by seasonal or perennial allergens. - Seasonal allergic rhinitis: control of symptoms during pollen seasons. - Nasal polyps: reduction of polyp size and improvement of nasal airflow.

Mometasone furoate may cause local and systemic adverse reactions. Most are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Altered taste or bitter taste. - Throat irritation or cough. - Dryness of nasal passages.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes or cataract formation. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal cavity. - Elevated intra‑ocular pressure or glaucoma exacerbation.

Before initiating therapy, consider the following safety measures: - Assess for active nasal or sinus infections: avoid use until infection resolves. - Use the lowest effective dose: limit duration to the prescribed period. - Monitor for signs of adrenal suppression: especially with long‑term or high‑dose therapy. - Caution in patients with glaucoma or cataracts: monitor intra‑ocular pressure. - Avoid use in children under two years of age unless specifically prescribed. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate can interact with other medications that affect corticosteroid metabolism or systemic exposure.

Major Interactions (Avoid): - Systemic corticosteroids: additive immunosuppression and adrenal effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase local steroid levels. - Nasal decongestant sprays used concurrently: risk of mucosal irritation.

Moderate Interactions (Monitor Closely): - Moderate CYP3A4 inhibitors (e.g., erythromycin): may modestly raise exposure. - Antifungal agents (e.g., fluconazole): monitor for increased local effects.